NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/03/2026
Voltar para busca
Dado oficial do USPTO
BIOMATION
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BIOMATION
ST13
US500000098254291Classe
7, 9, 10
Pedido
98254291
Registro
8188410
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
25/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
7, 9, 10
Data de depósito
03/11/2023
Data de registro
24/03/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/03/2026
Última transação
25/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
07/11/2023
Primeiro uso no comércio
07/11/2023
Código do desenho
4
Tipo de titular
03
Localização do titular
Manchester, NH, US
Examinador
STIGLITZ, SUSAN R
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
DEKA Research & Development Corp.
Representantes
Mark E. Tetreault
Classificação técnica
Classes Nice
Classe 7Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 7
Biomanufacturing devices for engineering of three-dimensional tissuesorgansautologous cell samples3D bioprinters; Fabrication devices for rejuvenation of tissuesorgansautologous cell samplestissue rejuvenation devices in the nature of bioprinters
Classe 9
Automated and semi-automated cell culture apparatus for laboratory useautomated fluid handling machines for cellular fluidsautomated cell separation machinesautomated cell culture chambers; Laboratory equipment and suppliesincubators for cell culturingcell therapytissue manufacturing and organ manufacturing and electronic monitors for monitoring cell culture incubators; Disposable plastic bioreactors for cell culturing; Biochips for the production of three-dimensional living tissuesorgans and autologous cell samples for research or scientific purposes; Bioreactors for cell culturing for laboratory use; Medical machinerycell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluid handling machines for cellular fluidsautomated cell separation machinesautomated cell culture chambers for the purpose of laboratory research; Automated and semi-automated medical equipment for the preparation of autologous and allogeneic biological cell therapies for medical purposesa fully integrated system composed primarily of computerselectronic sensorsmonitorsplastic tubingsyringespumpsmetal containersbottlesheating plates for use in the creation of biological cell therapiesorganstissues and autologous cell samples for medical purposes; Medical machinerycell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluidic handling for the purpose of medical and scientific research
Classe 10
Automated and semi-automated cell culture apparatus for medical useautomated fluid handling machines for cellular fluidsautomated cell separation machinesautomated cell culture chambers; Medical deviceselectromechanical fluidic instrumentsother similar or related deviceswhich process complex human body fluids for the purpose of separating human cell culture samplesseparating fluids; Medical instruments for processing of human body fluids in the nature of human cell samplesbloodplasmathe isolation and concentration of components thereof for the purpose of treating degenerative diseaseschronic diseases; Medical machinerycell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluidic handling for the purpose of therapeutic regenerative medical treatmentblood transfusionscell transfusions
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
24/03/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/03/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/03/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
03/03/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/03/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
03/03/2026
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
03/03/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/11/2025
GNRT
NON-FINAL ACTION E-MAILED
03/11/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
03/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/09/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/09/2025
ALIE
ASSIGNED TO LIE
29/09/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/09/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/09/2025
GNRT
NON-FINAL ACTION E-MAILED
10/09/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
10/09/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
24/07/2025
IUAF
USE AMENDMENT FILED
03/06/2024
EISU
TEAS STATEMENT OF USE RECEIVED
03/06/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/03/2024
PUBO
PUBLISHED FOR OPPOSITION
12/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/02/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/02/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
01/02/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/02/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
01/02/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/02/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
29/01/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
16/01/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/01/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
02/01/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/01/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
02/01/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/12/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
30/11/2023
GNRT
NON-FINAL ACTION E-MAILED
30/11/2023
CNRT
NON-FINAL ACTION WRITTEN
30/11/2023
DOCK
ASSIGNED TO EXAMINER
28/11/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/11/2023
NWAP
NEW APPLICATION ENTERED
07/11/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOMATION ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.